AGIOS PHARMACEUTICALS, INC. (AGIO) › Operating Cash FlowAGIOS PHARMACEUTICALS, INC. (AGIO) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2011: -$15.22M2012: -$49.55M2013: -$56.40M2015: -$76.95M2016: $38.56M2017: -$285.23M2018: -$304.42M2019: -$370.62M2020: -$290.76M2021: -$407.32M2022: -$309.48M2023: -$296.06M2024: -$389.84M2025: -$372.98M-$372.98M2011Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$372.98M+4.3%2024-$389.84M-31.7%2023-$296.06M+4.3%2022-$309.48M+24.0%2021-$407.32M-40.1%2020-$290.76M+21.5%2019-$370.62M-21.7%2018-$304.42M-6.7%2017-$285.23M-839.7%2016$38.56M+150.1%2015-$76.95M—2013-$56.40M-13.8%2012-$49.55M-225.6%2011-$15.22M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share